Update from the Canadian Dyspepsia Working Group

MeSH terms

• Canada
• Cisapride / adverse effects*
• Dyspepsia / diagnosis
• Dyspepsia / drug therapy*
• Dyspepsia / microbiology
• Gastroesophageal Reflux / drug therapy*
• Gastrointestinal Agents / adverse effects*
• Heart Diseases / chemically induced*
• Humans
• Patient Selection
• Practice Guidelines as Topic*
• United States
• United States Food and Drug Administration